Enovis Corporation
HealthcareNYSE:ENOV · New York Stock Exchange
+$0.68 today
Vol 0.91M · Avg 0.98M
Income Statement
Follow revenue through to earnings
Review sales, margins, expenses, and profit trends to see what is actually driving reported earnings over time.
Earnings Waterfall
Revenue to Net Income
Key Ratios
Analysis
$2.3B of revenue converted into -$1.1B of net income for the selected period. Gross margin is 56.8% and net margin is -50.6%, showing how much revenue survives after costs and taxes. EPS is $-20.02, tying the income statement back to per-share earnings.
Income Statement
Annual data · 5 periods
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $2.2B +6.7% | $2.1B +23.5% | $1.7B +9.2% | $1.6B +9.6% | $1.4B | $809.6M | $921.6M | $731.2M |
| Cost of Revenue | $902.8M -2.6% | $926.9M +29.4% | $716.4M +3.3% | $693.7M +7.0% | $648.5M | $725.6M | $804.0M | $882.4M |
| Gross Profit | $1.3B +13.9% | $1.2B +19.2% | $990.8M +14.0% | $869.4M +11.8% | $777.7M | $8.9B | $7.6B | $6.2B |
| Gross Margin | 59.8% +3.8pp | 56.0% -2.0pp | 58.0% +2.4pp | 55.6% +1.1pp | 54.5% | 9.8% | 28.9% | 38.3% |
| Research & Development | $120.3M +31.8% | $91.3M +21.2% | $75.3M +23.8% | $60.8M +23.9% | $49.1M | $983.2M | $1.3B | $490.4M |
| Selling, General & Admin | $1.1B +13.9% | $939.4M +13.1% | $830.3M +7.4% | $772.9M +16.1% | $665.8M | $620.6M | $923.0M | -$1.5B |
| Operating Expenses | $1.4B -30.3% | $2.0B +85.2% | $1.1B +12.3% | $940.6M +11.9% | $840.5M | $5.3B | $7.0B | $8.7B |
| Depreciation & Amortization | $294.4M +3.4% | $284.8M +31.2% | $217.1M -1.2% | $219.7M -16.4% | $262.9M | $374.2M | $1.2B | $631.8M |
| EBITDA | -$830.2M -72.6% | -$481.0M -383.4% | $169.7M -29.8% | $241.7M +42.0% | $170.3M | -$15.2B | $6.8B | $9.3B |
| EBITDA Margin | -36.9% -14.1pp | -22.8% -32.8pp | 9.9% -5.5pp | 15.5% +3.5pp | 11.9% | 5.6% | 46.3% | 42.0% |
| Operating Income | -$18.9M +97.6% | -$775.7M -1080.5% | -$65.7M +7.7% | -$71.2M -13.3% | -$62.8M | $12.3B | $14.0B | -$15.7B |
| Operating Margin | -0.8% +36.0pp | -36.8% -33.0pp | -3.8% +0.7pp | -4.6% -0.2pp | -4.4% | 16.6% | 24.1% | 22.0% |
| Interest Income | $0 | $0 | $0 -100.0% | $200.0K | $0 | -$1.5B | -$1.6B | $405.0M |
| Interest Expense | $34.8M -39.0% | $57.1M +189.1% | $19.7M -20.9% | $25.0M -14.3% | $29.1M | $1.1B | $1.0B | $1.2B |
| Other Income / Expenses | -$1.1B -2316.2% | -$47.2M -3226.6% | -$1.4M -102.1% | $69.1M +217.2% | -$59.0M | -$1.5B | $1.4B | $1.2B |
| Income Before Tax | -$1.2B -40.9% | -$822.9M -1125.9% | -$67.1M -3144.5% | -$2.1M +98.3% | -$121.8M | $3.3B | $4.9B | $3.6B |
| Pre-Tax Margin | -51.6% -12.5pp | -39.0% -35.1pp | -3.9% -3.8pp | -0.1% +8.4pp | -8.5% | 20.8% | 18.7% | 26.2% |
| Income Tax Expense | $22.3M +396.3% | $4.5M +133.8% | -$13.3M -136.8% | $36.1M +285.0% | -$19.5M | $1.3B | -$1.6B | $745.2M |
| Net Income | -$1.2B -43.5% | -$825.5M -2381.9% | -$33.3M -150.2% | -$13.3M -118.5% | $71.7M | $4.9B | $4.8B | $4.7B |
| Net Margin | -52.7% -13.5pp | -39.2% -37.2pp | -1.9% -1.1pp | -0.9% -5.9pp | 5.0% | 12.4% | 17.5% | 22.5% |
| EPS (Basic) | -$21 -39.7% | -$15 -2347.5% | -$1 -117.9% | -$0 +86.1% | -$2 | $400.8M | $703.2M | $1.3B |
| EPS (Diluted) | -$21 -39.7% | -$15 -2347.5% | -$1 -117.9% | -$0 +86.1% | -$2 | $766.2M | $609.4M | $452.6M |
| Weighted Avg Shares | $56.8M +2.7% | $55.3M +1.4% | $54.5M +0.9% | $54.1M +5.7% | $51.1M | $757.8M | $925.8M | $1.1B |
| Weighted Avg Shares (Diluted) | $56.8M +2.7% | $55.3M +1.4% | $54.5M +0.8% | $54.1M +5.7% | $51.1M | $1.2B | $924.4M | $678.0M |
Older periods hidden.
Sign in to unlockCompetitors
Peer companies in the same sector
ITT Inc.
NYSE:ITT
$16.91B
IDEX Corporation
NYSE:IEX
$16.17B
Watts Water Technologies, Inc.
NYSE:WTS
$11.12B
Donaldson Company, Inc.
NYSE:DCI
$10.01B
The Middleby Corporation
NASDAQ:MIDD
$7.17B
EnPro Industries, Inc.
NYSE:NPO
$7.07B
Franklin Electric Co., Inc.
NASDAQ:FELE
$4.58B
Kadant Inc.
NYSE:KAI
$3.34B
Helios Technologies, Inc.
NYSE:HLIO
$2.80B
The Gorman-Rupp Company
NYSE:GRC
$2.23B
Enerpac Tool Group Corp.
NYSE:EPAC
$1.85B
Graham Corporation
NYSE:GHM
$1.21B
Luxfer Holdings PLC
NYSE:LXFR
$488.28M
Omega Flex, Inc.
NASDAQ:OFLX
$311.71M
Hurco Companies, Inc.
NASDAQ:HURC
$139.89M
SEC Filings
Recent regulatory filings
No filings found.
How much revenue does ENOV generate?
Enovis Corporation (ENOV) reported $2.25B of revenue in fiscal 2025.
Is ENOV profitable?
Enovis Corporation (ENOV) reported -$1,184,440,000.00 of net income, with a net margin of -52.7%.
Explore More
Continue the stock analysis
Jump to another research area for this company.